Redesign Science

Redesign Science is a computational drug discovery company focusing on lead discovery against challenging and emerging drug targets, including protein-protein interactions. Its platform technology uses dynamic simulation at the atomic level to detect potential drugs and to guide the precise molecular design of novel th

Redesign Science is a company in prime based in New York, New York, US, founded in 2017.

Profile

Redesign Science is a computational drug discovery company focusing on lead discovery against challenging and emerging drug targets, including protein-protein interactions. Its platform technology uses dynamic simulation at the atomic level to detect potential drugs and to guide the precise molecular design of novel therapeutic candidates.

Its activity falls under prime; the profile below is assembled from public directory data.

The company is recorded as being based in New York, New York, US.

Its current recorded stage is Creative Destruction Lab alumni company.

Its team size is recorded as 11-50 employees.

Website: redesignscience.com